Friday, February 3

Tag: r&d

Healthcare Access and Equity: Women’s Health and Technology Hold the Keys
Science

Healthcare Access and Equity: Women’s Health and Technology Hold the Keys

While the quality of U.S. healthcare and patient outcomes has generally increased over time, access to care — and thus to positive patient outcomes — is not equitable to all people. Overall, one in 10 Americans don’t have health insurance, which is fallout of a system breaking under the weight of high costs and deepening complexity. Diabetes rates are more than 30% higher among Native Americans and Latinos than among Whites. Rates of death attributable to heart disease, stroke, and prostate and breast cancers remain much higher in black populations. If you live in a rural area and have a chronic disease (or multiple diseases) provider options are more limited than in densely populated areas. That means availability of a specialist or even the ability to get an appointment can be a chall...
Waymo bringing its autonomous driving technology to Los Angeles
Science

Waymo bringing its autonomous driving technology to Los Angeles

Waymo plans to bring its autonomous ride-sharing service to Los Angeles, joining behind Phoenix and San Francisco as the company looks for more cities to partner with. When it comes to miles traveled, Waymo leads the way with autonomous miles completed anywhere in the United States. 3VIEW GALLERY - 3 IMAGES Autonomous vehicles are becoming more prevalent, with automakers and tech companies partnering up to create safe, efficient vehicles to join regular drivers on the road.There are high expectations for Waymo in Los Angeles: 3 It makes sense Waymo wants to hit Los Angeles, which is the third largest ride-hailing service area in the country, with an estimated market opportunity of $2 billion this year alone.There are portions of the region well known for traffic safety issues and vehicle...
IBM hopes autonomous vessel technology can make waves in ship market
Science

IBM hopes autonomous vessel technology can make waves in ship market

Tech giant IBM expects its autonomous ship artificial intelligence technology used by commercial and research ships one day. The software is able to optimize decision-making by simulating different alternative choices and identifying possible issues while a ship is on the ocean. 2VIEW GALLERY - 2 IMAGES Earlier in 2022, the unmanned Mayflower Autonomous Ship (MAS) traveled 3,500 unmanned miles from Plymouth, United Kingdom to Halifax, Nova Scotia, Canada. The Atlantic Ocean crossing took 40 days and featured no human ship captain or onboard crew as it made the journey.Since naval companies tend to be slower to newer trends, fully autonomous ships probably won't happen for quite some time - but an AI-powered first officer might prove useful. The majority of marine accidents tend to involve...
What do retail and pharmacy have in common? How RFID technology can serve as part of a comprehensive solution to diversion
Science

What do retail and pharmacy have in common? How RFID technology can serve as part of a comprehensive solution to diversion

Retail and pharmacy – two very different industries that, on the surface, might not appear to have much in common. However, the two fields have found a use for an emerging technology to solve very similar problems. Radio frequency identification (RFID) technology is an incredibly valuable resource that has been introduced in the retail space to track inventory and detect and deter theft. Now, RFID is bringing immense value to the healthcare space,continuing to show promise and results, especially when incorporated into a comprehensive drug diversion prevention program. RFID technology uses wireless communication and radio waves to identify and track items and equipment. RFID tags can store a significant amount of data, whether it be a single serial number or several pages of material. Wi...
The new paradigm in drug development: Why platform technology is the solution patients and payers need
Science

The new paradigm in drug development: Why platform technology is the solution patients and payers need

We are living in a dynamic time of drug development and innovation with many beneficiaries—the most important being the patient. These developments include everything from exciting gene therapies for rare diseases to mRNA technology that allowed the development of the COVID vaccine in record time. Yet we are facing significant challenges as well. There is a global call for more equitable pricing and broader access—especially for the newer innovative treatments. How can we as healthcare leaders answer that call? How can we work with our stakeholders to ensure that the system can effectively support new innovations so that the most important stakeholder—the patient—will benefit? Collaboration and partnerships In answering the call, we must focus our attention on where it has the most impa...